<!DOCTYPE html>
<html>

<head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, shrink-to-fit=no">
    <title>Bharat Biotech Covid Vaccine</title>
    <link rel="stylesheet" href="assets/bootstrap/css/bootstrap.min.css">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Bitter:400,700">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Lora">
    <link rel="stylesheet" href="assets/fonts/font-awesome.min.css">
    <link rel="stylesheet" href="assets/fonts/ionicons.min.css">
    <link rel="stylesheet" href="assets/css/Article-Clean.css">
    <link rel="stylesheet" href="assets/css/Footer-Dark.css">
    <link rel="stylesheet" href="assets/css/Header-Dark.css">
    <link rel="stylesheet" href="assets/css/styles.css">
    <link rel="apple-touch-icon" sizes="180x180" href="apple-touch-icon.png">
    <link rel="icon" type="image/png" sizes="32x32" href="favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="favicon-16x16.png">
    <link rel="manifest" href="site.webmanifest">
</head>

<body>
    <div>
        <div class="header-dark">
            <nav class="navbar navbar-dark navbar-expand-lg navigation-clean-search">
                <div class="container">
                    <img src="../logo.png" alt="logo" style="height: 25px; width: 25px;">
                    <a class="navbar-brand" href="../../index.html">&nbsp; Explorax</a><button data-toggle="collapse" class="navbar-toggler" data-target="#navcol-1"><span class="sr-only">Toggle navigation</span><span class="navbar-toggler-icon"></span></button>
                    <div class="collapse navbar-collapse"
                        id="navcol-1">
                        <ul class="nav navbar-nav">

                            <li class="nav-item dropdown"><a class="dropdown-toggle nav-link" data-toggle="dropdown" aria-expanded="false" href="#">News Categories </a>
                                <div class="dropdown-menu" role="menu">
                                    <a class="dropdown-item" role="presentation" href="../tech.html">Technology</a>
                                    <a class="dropdown-item" role="presentation" href="../sports.html">Sports</a>
                                    <a class="dropdown-item" role="presentation" href="../entertainment.html">Entertainment</a>
                                    <a class="dropdown-item" role="presentation" href="../international.html">International</a>
                                    <a class="dropdown-item" role="presentation" href="../national.html">National</a>
                                    <a class="dropdown-item" role="presentation" href="../education.html">Education</a>
                                    <a class="dropdown-item" role="presentation" href="../lifestyle.html">Lifestyle</a>
                                    <a class="dropdown-item" role="presentation" href="../covid.html">COVID-19</a>
                                </div>
                            </li>
                            <li class="nav-item" role="presentation"><a class="nav-link" href="../../kiit.html">KIIT Updates</a></li>
                            <li class="nav-item" role="presentation"><a class="nav-link" href="../../blog.html">Blogs</a></li>
                        </ul>
                        <form class="form-inline mr-auto" target="_self">
                            
                        </form><span class="navbar-text"><a class="login" href="../../about-us.html">About</a></span><a class="btn btn-light action-button" role="button" href="../../contact.html">Contact Us</a></div>
                </div>
                
                
            </nav><br><img src="../full.png" alt="Logo" style="width: 600px; height: 250px; display: block; margin-left: auto; margin-right: auto;">
            <div class="container hero">
                <div class="row">
                    <div class="col-md-8 offset-md-2">
                      <!--   <img src="" alt="">   --> 

                    </div>
                </div>
            </div>
        </div>
    </div>
    <div class="article-clean">
        <div class="container">
            <div class="row">
                <div class="col-lg-10 col-xl-8 offset-lg-1 offset-xl-2">
                    <div class="intro">
                        <h1 class="text-center">Bharat Biotech asked to submit complete phase-2 data of its COVID-19 vaccine before phase-3 trial  </h1>
                        
                        <p class="text-center"> <span>October 10, 2020 </span></p>
                            <img class="img-fluid" src="./pic/covaxin-big.jpg"></div> 
                    
                        <div class="text">

                            <!-- 
                                To insert paragraph:        <p>         Text       </p>    
                                To give subheading:         <h2>        Text       </h2>
                                To Underline your text:     <span style="text-decoration: underline;"> Text </span>
                                To make your text bold:     <strong>    Text       </strong>
                                To make your text Italics:  <em>        Text       </em>
                                To add extra image:         <figure><img class="figure-img" src="./pic/IMAGE NAME (HD or 4K picture only) >">
                                                                    <figcaption><em>CHANGE 3 : IMAGE Caption</em></figcaption>
                                                            </figure>
                            -->
                        <!--        CHANGE 5 : According to Your Article ADD/REMOVE adequate numbers of paragraphs and images     -->    
                        <h2>According to officials, Bharat Biotech applied to the DCGI on Oct. 2, seeking its permission to conduct phase-3 randomised double-blind placebo-controlled multicentre trial of its COVID-19 vaccine candidate </h2>

                        <p>  Bharat Biotech, which had sought DCGI’s nod for conducting phase-3 clinical trials of its COVID-19 vaccine candidate, has been asked to submit complete safety and immunogenicity data of the ongoing phase-2 trial, besides providing some clarifications, before proceeding for the next stage.  </p>
                        <p>The vaccine candidate— ‘Covaxin’ — is being indigenously developed by the Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR). </p>
                        <p>According to officials, the Hyderabad-based vaccine maker applied to the Drugs Controller General of India (DCGI) on October 2, seeking its permission to conduct phase-3 randomised double-blind placebo-controlled multicentre trial of its COVID-19 vaccine candidate.</p>
                        <p>The firm in its application said that the study would cover 28,500 subjects aged 18 years and above and would be conducted in 19 sites — including Delhi, Mumbai, Patna and Lucknow — across 10 States.</p>
                        <p>According to sources, the phase-2 trial of Covaxin is going on and the second dose is yet to be given to volunteers at some sites. </p>

                       

                        <figure><img class="figure-img" src="./pic/Bharat_Biotech.jpg">
                            
                        </figure>

                        <p>“The company presented phase-3 clinical trial protocol along with interim data of phase 1 and 2 clinical trials,” an official said. </p>
                        <p>The subject expert committee (SEC) at the Central Drugs Standard Control Organisation(CDSCO) deliberated on the application on October 5.</p>
                        <p>“After a detailed deliberation, the committee opined that the design of the phase-3 study is in principle satisfactory except for clarification on definition of asymptomatic, etc. </p>
                        <p>“However, the study should be initiated with appropriate dose identified from the phase-2 safety and immunogenicity data. Accordingly, the firm should submit safety and immunogenicity data from phase-2 trial for consideration,” the panel said in its recommendations.</p>
                        <p>The SEC during its discussion also observed that the vaccine was well-tolerated in all dose groups and no serious adverse events have been reported so far, a source said.</p>
                        <p>The most common adverse event was pain at the injection site, which resolved transiently, the source said.</p>
                        <p>The phase-3 clinical trial application proposed a dose of 0.5 ml on day 0 and 28, sources said.</p>
                        <p>Besides, Bharat Biotech, indigenously developed vaccine candidate by Zydus Cadila Ltd is in the phase 2 of the human clinical trials.</p>
                        <p>The Pune-based Serum Institute of India, which has partnered with AstraZeneca for manufacturing the Oxford COVID-19 vaccine candidate, is also conducting Phase 2 and 3 human clinical trials of the candidate in India.</p>
                    </div>
                </div>
            </div>
        </div>
    </div>
    <div class="footer-dark">
        <footer>
            <div class="container">
                <div class="row">
                    <div class="col-sm-6 col-md-3 item">
                        <h3>Services</h3>
                        <ul>
                            <li><a href="#">News</a></li>
                            <li><a href="#">Blogging</a></li>
                            <li><a href="#">KIIT Updates</a></li>
                        </ul>
                    </div>
                    <div class="col-sm-6 col-md-3 item">
                        <h3>News Categories</h3>
                        <ul>
                            <li><a href="#">Technology</a></li>
                            <li><a href="#">Education</a></li>
                            <li><a href="#">Sports</a></li>
                            <li><a href="#">Others</a></li>
                        </ul>
                    </div>
                    
                    <div class="col-md-6 item text">
                        <h3>Explorax</h3>
                        <p>Praesent sed lobortis mi. Suspendisse vel placerat ligula. Vivamus ac sem lacus. Ut vehicula rhoncus elementum. Etiam quis tristique lectus. Aliquam in arcu eget velit pulvinar dictum vel in justo.</p>
                    </div>
                    <div class="col item social">
                        <a href="#"><i class="icon ion-social-facebook"></i></a>
                        <a href="#"><i class="icon ion-social-instagram"></i></a>
                        <a href="#"><i class="icon ion-social-twitter"></i></a>
                        <a href="#"><i class="icon ion-social-linkedin"></i></a>
                    </div>
                </div>
                <p class="copyright">Explorax © 2020</p>
            </div>
        </footer>
    </div>
    <script src="assets/js/jquery.min.js"></script>
    <script src="assets/bootstrap/js/bootstrap.min.js"></script>
</body>

</html>